These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 33905426)

  • 21. Impact of hepatitis B and delta virus co-infection on liver disease in Mauritania: a cross sectional study.
    Lunel-Fabiani F; Mansour W; Amar AO; Aye M; Le Gal F; Malick FZ; Baïdy L; Brichler S; Veillon P; Ducancelle A; Gordien E; Rosenheim M
    J Infect; 2013 Nov; 67(5):448-57. PubMed ID: 23796871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Virological and clinical characteristics of hepatitis delta virus in South Asia.
    Mumtaz K; Ahmed US; Memon S; Khawaja A; Usmani MT; Moatter T; Hamid S; Jafri W
    Virol J; 2011 Jun; 8():312. PubMed ID: 21689416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology, Natural History, and Treatment of Hepatitis Delta Virus Infection in HIV/Hepatitis B Virus Coinfection.
    Ferrante ND; Lo Re V
    Curr HIV/AIDS Rep; 2020 Aug; 17(4):405-414. PubMed ID: 32607773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coinfection with hepatitis B and D: epidemiology, prevalence and disease in patients in Northern California.
    Gish RG; Yi DH; Kane S; Clark M; Mangahas M; Baqai S; Winters MA; Proudfoot J; Glenn JS
    J Gastroenterol Hepatol; 2013 Sep; 28(9):1521-5. PubMed ID: 23574043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A regular screening for hepatitis delta virus among chronic hepatitis B carriers improves the diagnostic of this infection and of subsequent cirrhosis development.
    Weichselbaum L; Njimi H; van den Wijngaert S; Dahma H; Nkuize M; Van Gossum M; Eisendrath P; Mulkay JP; Sersté T
    United European Gastroenterol J; 2024 May; 12(4):516-525. PubMed ID: 38520063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study.
    Manesis EK; Vourli G; Dalekos G; Vasiliadis T; Manolaki N; Hounta A; Koutsounas S; Vafiadis I; Nikolopoulou G; Giannoulis G; Germanidis G; Papatheodoridis G; Touloumi G
    J Hepatol; 2013 Nov; 59(5):949-56. PubMed ID: 23850875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of worse liver-related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort.
    d'Arminio Monforte A; Tavelli A; Salpini R; Piermatteo L; D'Anna S; Carrara S; Malagnino V; Mazzotta V; Brancaccio G; Marchetti GC; Rosselli Del Turco E; Rossotti R; Mussini C; Antinori A; Lo Caputo S; Ceccherini Silberstein F; Gaeta GB; Svicher V; Puoti M;
    Liver Int; 2024 Feb; 44(2):603-613. PubMed ID: 38100128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B/D-Related Hepatocellular Carcinoma. A Clinical Literature Review.
    Baskiran A; Atay A; Baskiran DY; Akbulut S
    J Gastrointest Cancer; 2021 Dec; 52(4):1192-1197. PubMed ID: 34611832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical long-term outcome of hepatitis D compared to hepatitis B monoinfection.
    Wranke A; Heidrich B; Deterding K; Hupa-Breier KL; Kirschner J; Bremer B; Cornberg M; Wedemeyer H
    Hepatol Int; 2023 Dec; 17(6):1359-1367. PubMed ID: 37789170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of hepatocellular carcinoma in hepatitis B and D virus co-infected patients: A systematic review and meta-analysis of longitudinal studies.
    Kamal H; Fornes R; Simin J; Stål P; Duberg AS; Brusselaers N; Aleman S
    J Viral Hepat; 2021 Oct; 28(10):1431-1442. PubMed ID: 34291520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
    Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
    J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High prevalence of hepatitis delta virus among patients with chronic hepatitis B virus infection and HIV-1 in an intermediate hepatitis B virus endemic region.
    Saravanan S; Madhavan V; Velu V; Murugavel KG; Waldrop G; Solomon SS; Balakrishnan P; Kumarasamy N; Smith DM; Mayer KH; Solomon S; Thyagarajan SP
    J Int Assoc Provid AIDS Care; 2014; 13(1):85-90. PubMed ID: 23722085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis delta infection among persons living with HIV in Europe.
    Béguelin C; Atkinson A; Boyd A; Falconer K; Kirkby N; Suter-Riniker F; Günthard HF; Rockstroh JK; Mocroft A; Rauch A; Peters L; Wandeler G;
    Liver Int; 2023 Apr; 43(4):819-828. PubMed ID: 36625770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innate immune recognition and modulation in hepatitis D virus infection.
    Jung S; Altstetter SM; Protzer U
    World J Gastroenterol; 2020 Jun; 26(21):2781-2791. PubMed ID: 32550754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of hepatitis D virus infection among patients with chronic hepatitis B infection in a tertiary care centre in Thailand.
    Ananchuensook P; Suksawatamnuay S; Thaimai P; Siripon N; Sriphoosanaphan S; Thanapirom K; Poovorawan Y; Komolmit P
    Sci Rep; 2023 Dec; 13(1):22633. PubMed ID: 38114689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study.
    Marcon PDS; Tovo CV; Kliemann DA; Fisch P; de Mattos AA
    World J Gastroenterol; 2018 Feb; 24(5):613-622. PubMed ID: 29434450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presence of acute hepatitis D infection in HBsAg positive cancer patients: A preliminary study from west Gujarat.
    Patel FM; Goswami PN
    Indian J Med Res; 2016 Jun; 143(6):798-800. PubMed ID: 27748305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and predictors for compensated Advanced Chronic Liver Disease (c-ACLD) in patients with chronic Hepatitis Delta Virus (HDV) infection.
    Couto I; Victoria M; Veloso VG; Rodrigues L; Grinsztejn B; Lacerda M; Victoria F; Perazzo H
    PLoS One; 2017; 12(3):e0174453. PubMed ID: 28329027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study.
    Sheng WH; Hung CC; Kao JH; Chang SY; Chen MY; Hsieh SM; Chen PJ; Chang SC
    Clin Infect Dis; 2007 Apr; 44(7):988-95. PubMed ID: 17342655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of delta virus infection on the virologic status in Egyptian patients with chronic hepatitis B virus genotype D.
    Fouad R; Abdo M; Eldeen HG; Sabry D; Atef M; Ahmed R; Zayed N
    J Med Virol; 2016 May; 88(5):837-42. PubMed ID: 26488214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.